We are proud to announce that our team received a  for our innovative solution developed within the project "Luminescent theranostic compounds with anticancer activity — combining photodynamic therapy and diagnostics through imaging in a single molecule, and the development of 3D-printed local microneedle systems for precise, individualized cancer therapy."

This recognition highlights the interdisciplinary nature and scientific excellence of our work, which integrates advanced photodynamic therapy, molecular imaging, and personalized drug delivery technologies to create a novel approach to cancer treatment.

The award reflects our team’s commitment to innovation, collaboration, and the translation of scientific discoveries into practical healthcare applications.